financetom
Business
financetom
/
Business
/
CNS Pharmaceuticals Receives More Time to Regain Compliance With Nasdaq Listing Requirement
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CNS Pharmaceuticals Receives More Time to Regain Compliance With Nasdaq Listing Requirement
Nov 1, 2024 4:26 PM

12:34 PM EDT, 11/01/2024 (MT Newswires) -- CNS Pharmaceuticals ( CNSP ) said Friday that a Nasdaq hearings panel has given it more time regain compliance with the exchange's minimum bid price requirement.

The company said it was granted until March 11, 2025 to regain compliance with the listing rule.

CNS shares were 1.3% higher in recent trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved